488 related articles for article (PubMed ID: 28648865)
1. Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery.
Elezaby RS; Gad HA; Metwally AA; Geneidi AS; Awad GA
J Control Release; 2017 Sep; 261():43-61. PubMed ID: 28648865
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
[TBL] [Abstract][Full Text] [Related]
4. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
5. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
[TBL] [Abstract][Full Text] [Related]
7. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
8. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNS.
Gagliardi M; Bardi G; Bifone A
Ther Deliv; 2012 Jul; 3(7):875-87. PubMed ID: 22900468
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
11. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanocarriers for CNS-targeted drug delivery.
Micheli MR; Bova R; Magini A; Polidoro M; Emiliani C
Recent Pat CNS Drug Discov; 2012 Apr; 7(1):71-86. PubMed ID: 22283231
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
15. Advances in designing of polymeric micelles for biomedical application in brain related diseases.
Kaur J; Gulati M; Kapoor B; Jha NK; Gupta PK; Gupta G; Chellappan DK; Devkota HP; Prasher P; Ansari MS; Aba Alkhayl FF; Arshad MF; Morris A; Choonara YE; Adams J; Dua K; Singh SK
Chem Biol Interact; 2022 Jul; 361():109960. PubMed ID: 35533733
[TBL] [Abstract][Full Text] [Related]
16. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
Dilnawaz F; Sahoo SK
Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
[TBL] [Abstract][Full Text] [Related]
18. Enhanced blood-brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider.
Ding J; Sun Y; Li J; Wang H; Mao S
J Drug Target; 2017 Jul; 25(6):532-540. PubMed ID: 28151022
[TBL] [Abstract][Full Text] [Related]
19. Biomedical Application of Polymers: A Case Study of Non-CNS Drugs Becoming CNS Acting Drugs.
Saganuwan SA
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):32-38. PubMed ID: 28828968
[TBL] [Abstract][Full Text] [Related]
20. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
Gu L; Faig A; Abdelhamid D; Uhrich K
Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]